Cell Culture & Cell-Based Bioassay Services
Accelerate your biologic drug development with rapid, reliable bioassay services that go beyond routine molecular separation. Access our proven platform methods, specialized expertise, and regulatory guidance to streamline development from discovery through commercialization. Our comprehensive testing support and end-to-end solutions help bring your biologics to market faster.

What is Cell Culture & Cell-Based Bioassay Testing at Element?
Cell-based bioassays determine drug potential and efficacy throughout biologic development, providing critical data for product analysis and regulatory submissions. At Element, we provide a comprehensive suite of bioassay services that goes well beyond routine molecular separation and sample analysis, from initial candidate assessment through lot release and stability testing, supporting you with a dedicated BSL-2 facility for all cell types.

What Can Element Offer You For Cell Culture & Cell-Based Bioassay Services?
Products We Test
Products We Test
Our BSL-2 facility handles all cell types including immortalized cell lines (MDCK), primary cells, and diverse tissue samples from brain, blood, and milk. We support both monolayer and suspension formats, enabling comprehensive testing across multiple biologic drug modalities including peptides, mAbs, proteins/enzymes, ADCs, gene therapies, cancer vaccines, and cell therapies. Our extensive experience covers testing requirements throughout the entire development lifecycle.
Key tests offered
Key tests offered
We deliver custom potency assay development and validation per ICH guidance, alongside comprehensive cellular analysis. Potency assays are arguably the most important cell-based bioassays, as these assessments are needed to demonstrate proof of activity. Our testing capabilities include:
- Cell proliferation and viability determination
- Cytokine screens and reporter gene assays
- Gene expression and cell signaling assays
- Ligand binding assays
- Cell death and apoptosis testing
- Cytotoxicity studies
- Drug target identification and isolation from tissue samples
Methods and solutions offered
Methods and solutions offered
Access our established platform methods for rapid implementation, significantly reducing development time by eliminating the need to start and develop assays from scratch. Get complete support from discovery through commercialization, including method optimization. Our solutions encompass stability assessments, routine lot testing, media qualification and characterization. We provide IND/BLA submission support and regulatory consulting throughout your development journey.
- Comprehensive bioassay capabilities:
- Potency assays: Custom bioassay development and validation per ICH guidance, including biologic drug cellular uptake and cellular response to a biologic drug
- Bioassay method optimization
- Drug permeability assays
- Cell proliferation and viability determination (MTT/MTS assays)
- Cytokine screens
- Reporter gene assays by fluorescence
- Gene expression analysis
- Cell signaling assays
- Ligand binding assays
- Cell death and apoptosis testing
- Cytotoxicity studies
- Drug target identification and isolation from tissue samples
- Biologic drug characterization
- Basic research and drug discovery
- Biologics License Application (BLA) submission support
- Routine lot testing
- Potency testing within a stability assessment
- Media qualification and characterization
Which labs offer this service
Which labs offer this service
Our team operates from Life Sciences hubs across the world, providing global access to our expert capabilities. Find out where your nearest Life Sciences hub is on our Locations Page.
Specialized expertise
Specialized expertise
Our team provides tailored bioassay solutions for various applications, leveraging accumulated knowledge to eliminate the need for developing assays from scratch. Leading biopharmaceutical companies rely on our cell culture facility and bioassay laboratory to verify their drug objectives and development programs. We understand the unique challenges of large molecule therapies. Our expertise spans from determining candidates and making initial investment decisions to lot release and stability testing for biologic drug development.
Standards we test to and products we test
Biologic Drug Modalities:
- Peptides
- Monoclonal antibodies (mAbs)
- Proteins/enzymes
- Antibody-drug conjugates (ADCs)
- Lentivirus/adeno-associated virus gene therapies
- Cancer vaccines
- Cell therapies
Cell Types:
- Immortalized cell lines (e.g., MDCK)
- Primary cells
- Tissue samples (brain, blood, milk)
- Monolayer formats
- Suspension formats
Your Challenges, Our Solutions
Rapid development pathway achieved
Regulatory-ready data delivered
Complex bioassays made reliable
Comprehensive support delivered
Why Choose Element

Complete bioassay solutions
Accelerated development
Comprehensive modality experience
Full testing support
Frequently asked questions
What drug development stages do you support?
Our comprehensive testing solutions support the entire product lifecycle.

Explore our global network of labs and find your nearest location
VIEW ALL LOCATIONSRelated services

Extractables and Leachables Testing Services
Element provides tailored extractables and leachables testing (E&L) studies to ensure patient safety and compliance with regulatory requirements.

Trace Metal Testing and Analysis Services
Element offers trace metal testing and impurity analysis services, addressing safety, compliance, and contamination challenges for pharmaceutical products with advanced techniques and global expertise.

Biopharmaceuticals & Biologics Analysis Services
Our clients develop safe, efficacious products with confidence thanks to Element’s Biologics and Advanced Therapy Medicinal Products (ATMPS) testing services.
